Atsuko Kimura Selected Research

Migraine Disorders (Migraine)

3/2015	Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling.
2/2015	Valproic acid prevents retinal degeneration in a murine model of normal tension glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsuko Kimura Research Topics

Disease

13	Retinal Degeneration 01/2019 - 11/2009
11	Glaucoma 09/2020 - 11/2014
9	Low Tension Glaucoma 03/2022 - 11/2009
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2023 - 04/2011
5	Multiple Sclerosis 01/2023 - 04/2011
5	Optic Nerve Injuries 09/2020 - 10/2014
5	Optic Neuritis (Retrobulbar Neuritis) 12/2017 - 04/2011
4	Vision Disorders (Hemeralopia) 12/2017 - 04/2015
3	Neuroinflammatory Diseases 01/2022 - 12/2017
3	Demyelinating Diseases (Demyelinating Disease) 12/2017 - 04/2011
3	Mood Disorders (Mood Disorder) 03/2015 - 07/2009
2	Brain Infarction 01/2017 - 01/2017
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2017 - 01/2017
2	Migraine Disorders (Migraine) 03/2015 - 02/2015
2	Neuralgia (Stump Neuralgia) 03/2015 - 02/2015
2	Epilepsy (Aura) 03/2015 - 02/2015
1	Neuromyelitis Optica (Devic's Disease) 01/2024
1	Infections 01/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2023
1	Macular Degeneration (Age-Related Maculopathy) 03/2022
1	Erythema 05/2021
1	Retinal Diseases 09/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2016
1	Neoplasms (Cancer) 11/2014
1	Alzheimer Disease (Alzheimer's Disease) 11/2014
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2014
1	Micrognathism 04/2011
1	Mental Disorders (Mental Disorder) 07/2009
1	Anxiety Disorders (Anxiety Disorder) 07/2009
1	Feeding and Eating Disorders (Eating Disorder) 07/2009

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 03/2022 - 10/2014
6	Neuroprotective AgentsIBA 01/2018 - 03/2015
4	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 03/2022 - 01/2019
4	Excitatory Amino AcidsIBA 01/2019 - 07/2015
4	Valproic Acid (Depakote)FDA LinkGeneric 01/2017 - 02/2015
3	MAP Kinase Kinase Kinase 5IBA 01/2022 - 01/2017
3	AntioxidantsIBA 09/2020 - 04/2011
3	Glutamic Acid (Glutamate)FDA Link 09/2020 - 02/2011
3	SpermidineIBA 01/2017 - 04/2011
2	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2022 - 03/2017
2	K-115IBA 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2014
2	Ophthalmic Solutions (Eye Drops)IBA 01/2019 - 04/2015
2	N-Methylaspartate (NMDA)IBA 01/2019 - 03/2015
2	EdaravoneIBA 01/2017 - 01/2017
2	Free Radical ScavengersIBA 01/2017 - 01/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2016 - 12/2015
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2024
1	Galactosylceramides (Galactocerebrosides)IBA 01/2023
1	GlycolipidsIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2020
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2017
1	LipopolysaccharidesIBA 12/2017
1	candesartanIBA 12/2017
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 03/2017
1	SteroidsIBA 01/2017
1	EnzymesIBA 01/2017
1	Nerve Growth Factor (NGF)IBA 09/2016
1	Nerve Growth Factors (Neurotrophins)IBA 09/2016
1	Ciliary Neurotrophic Factor (CNTF)IBA 09/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2016
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 09/2016
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 04/2015
1	p38 Mitogen-Activated Protein KinasesIBA 10/2014
1	SB 203580IBA 10/2014
1	diacetyldichlorofluoresceinIBA 04/2011
1	Interleukin-1 (Interleukin 1)IBA 11/2009
1	LigandsIBA 07/2009
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2009
1	Antidepressive Agents (Antidepressants)IBA 07/2009
1	Anti-Anxiety Agents (Anxiolytics)IBA 07/2009
1	5-HT2C Serotonin ReceptorIBA 07/2009

Therapy/Procedure

7	Therapeutics 01/2024 - 09/2016
2	Intraperitoneal Injections 01/2017 - 02/2015
1	Blood Component Removal (Apheresis) 05/2021
1	Oral Administration 12/2017
1	Caloric Restriction 09/2016
1	Topical Administration 04/2015
1	Airway Management 04/2011